A TERMINALLY-ill chef has vowed to run her 600th marathon by the summer. Doctors diagnosed Brenda O’Keeffe, 48, from Co Cavan, with a rare and untreatable type of bone marrow cancer last year. The ...

While researchers are grateful they can offer patients one of the two approved stabilizers, better therapeutics are still ...

Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and ...

Palo Alto, California Thursday, February 13, 2025, 12:00 Hrs [IST] ...

Susan Lee Trentham Tupper, 67, of Rockwood, Tennessee, formerly of Clinton, passed away on Tuesday, February 11, 2025, at ...

Nearly 3 months after the FDA green-lit the TTR stabilizer, it joins tafamidis as the second therapy in Europe for the ...

The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...

The European Commission (EC) has granted marketing authorisation to BridgeBio Pharma’s selective small molecule, acoramidis, ...

The European Commission has granted marketing authorization in the European Union (EU) for acoramidis, under the brand name ...